Fatao D. Liu

1665 Kongjiang Road
Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Distinct mutation landscape with similar immune microenvironment in primary simultaneous operable squamous cell carcinoma and peripheral-type small-cell lung cancer.

Distinct mutation landscape with similar immune microenvironment in primary simultaneous operable squamous cell carcinoma and peripheral-type small-cell lung cancer.

Journal: Translational lung cancer research

Published: December 15, 2025

Macrophage-rich niches regulate T cell dynamics at the liver invasive margin during gallbladder cancer progression.

Macrophage-rich niches regulate T cell dynamics at the liver invasive margin during gallbladder cancer progression.

Journal: The Journal of clinical investigation

Published: March 24, 2025

Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing.

Full-length transcriptome atlas of gallbladder cancer reveals trastuzumab resistance conferred by ERBB2 alternative splicing.

Journal: Signal transduction and targeted therapy

Published: September 08, 2024

Super-Enhancer Reprograming Driven by SOX9 and TCF7L2 Represents Transcription-Targeted Therapeutic Vulnerability for Treating Gallbladder Cancer.

Super-Enhancer Reprograming Driven by SOX9 and TCF7L2 Represents Transcription-Targeted Therapeutic Vulnerability for Treating Gallbladder Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: June 11, 2024

Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders.

Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders.

Journal: Cancer cell

Published: November 09, 2023

SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.

SNHG15 promotes gallbladder cancer progression by enhancing the autophagy of tumor cell under nutrition stress.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 08, 2023

Mutational signatures in 175 Chinese gastric cancer patients.

Mutational signatures in 175 Chinese gastric cancer patients.

Journal: BMC cancer

Published: November 05, 2023

Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.

Acylcarnitines promote gallbladder cancer metastasis through lncBCL2L11-THOC5-JNK axis.

Journal: Journal of translational medicine

Published: October 03, 2023

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.

EMP3 as a key downstream target of miR-663a regulation interferes with MAPK/ERK signaling pathway to inhibit gallbladder cancer progression.

Journal: Cancer letters

Published: July 30, 2023

Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial.

Afatinib in combination with GEMOX chemotherapy as the adjuvant treatment in patients with ErbB pathway mutated, resectable gallbladder cancer: study protocol for a ctDNA-based, multicentre, open-label, randomised, controlled, phase II trial.

Journal: BMJ open

Published: February 28, 2023

Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer.

Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer.

Journal: Frontiers of medicine

Published: November 14, 2022

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].

Retraction notice to "EMP3, which is regulated by miR-663a, suppresses gallbladder cancer progression via interference with the MAPK/ERK pathway" [Canc. Lett. 430 (2018) 97-108].

Journal: Cancer letters

Published: October 10, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026